Hanover (THG) EVP Dennis Kerrigan reports new stock awards and options
Rhea-AI Filing Summary
Hanover Insurance Group Executive Vice President Dennis Francis Kerrigan reported equity awards under the company’s long-term incentive plans. On February 24, 2026, he acquired 5,328 stock options with an exercise price of $0.0000 per share and 1,730 shares of common stock at no cost.
He also received additional common stock awards of 1,115 shares and 1,117 shares, each reported as grants or other acquisitions, bringing his direct common stock holdings to 13,719.585 shares. Footnotes indicate that related performance-based and restricted stock unit awards vest over multi‑year periods, with some vesting on February 27, 2026, and options vesting in thirds on each of the first three anniversaries of grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 3,962 shares
Net Buy
4 txns
Insider
Kerrigan Dennis Francis
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Option (right to buy) | 5,328 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,730 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,115 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,117 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock Option (right to buy) — 5,328 shares (Direct);
Common Stock — 13,719.585 shares (Direct)
Footnotes (4)
- F1. On February 27, 2023, the Reporting Person was granted performance-based restricted stock units ("PBRSUs") pursuant to the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP"). These PBRSUs were subject to a performance-based vesting condition related to three-year average adjusted return on equity and a time-based vesting condition, and also provided for the accumulation of dividend equivalent rights. On February 24, 2026, the performance condition for this award was certified at 150% of the target award (as adjusted for accumulated dividend equivalent rights). This award remains subject to the time-based vesting condition and will vest on February 27, 2026.
- F2. On February 27, 2023, the Reporting Person was granted PBRSUs pursuant to the Issuer's 2022 LTIP. These PBRSUs were subject to a performance-based vesting condition related to three-year relative total shareholder return and a time-based vesting condition, and also provided for the accumulation of dividend equivalent rights. On February 24, 2026, the performance condition for this award was certified at 100% of the target award (as adjusted for accumulated dividend equivalent rights). This award remains subject to the time-based vesting condition and will vest on February 27, 2026.
- F3. Grant of restricted stock units under the Issuer's 2022 LTIP. Such units vest on the third anniversary of the date of grant.
- F4. Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date.
FAQ
What did Hanover (THG) Executive Vice President Dennis Francis Kerrigan report on this Form 4?
Dennis Francis Kerrigan reported several equity awards from Hanover Insurance Group. These included stock options and multiple common stock grants received at no cost, reflecting compensation under the company’s long-term incentive plans rather than open-market purchases or sales.
How many stock options did Dennis Francis Kerrigan receive from Hanover (THG)?
He received 5,328 stock options labeled as a grant or other acquisition. These options have an exercise price of $0.0000 per share and vest in thirds on each of the first three anniversaries of the grant date, according to the footnotes.
How do the performance-based restricted stock units for Hanover (THG) vest for Dennis Francis Kerrigan?
Footnotes explain that earlier performance-based restricted stock units had performance certified at 150% and 100% of target, as adjusted for dividend equivalents. These awards remain subject to time-based vesting and are scheduled to vest on February 27, 2026, under the 2022 long-term plan.
Are the Hanover (THG) equity awards to Dennis Francis Kerrigan open-market purchases or compensation grants?
They are compensation grants, not market purchases. Each transaction is coded as a grant or other acquisition at a price of $0.0000 per share, consistent with stock options, restricted stock units, and performance-based awards issued under Hanover’s long-term incentive plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
